DMAC

DiaMedica Therapeutics Inc.

Latest Form 4:Purchase$1.2MbySTAHLBERG JAN (10% Owner) · filed Dec 8, 2025

DiaMedica Therapeutics Inc. (DMAC) has 6 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 12, 2026.

The most active filer is 10% Owner STAHLBERG JAN with 7 filings.

  • Industry:Biotechnology
  • CEO:Dietrich John Pauls
  • Employees:35
  • HQ:Minneapolis, MN, US
  • IPO:2012-08-03

Insider Buying

$7.6M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$364.0M

latest known value

Source
STAHLBERG JANFirst filing
Purchase$1.2MDec 8SEC ↗
STAHLBERG JANFirst filing
Purchase$1.2MDec 8SEC ↗
STAHLBERG JANFirst filing
Purchase$1.7MDec 8SEC ↗
STAHLBERG JANFirst filing
Purchase$951KDec 8SEC ↗
STAHLBERG JANFirst filing
Purchase$1.5MDec 8SEC ↗
STAHLBERG JANFirst filing
Purchase$318KDec 8SEC ↗
STAHLBERG JANFirst filing
Purchase$627KDec 8SEC ↗

Related companies

DiaMedica Therapeutics Inc. is in the Healthcare sector.